We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+14.1%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$19.8B
AUM Growth
+$2.97B
(+18%)
Cap. Flow
+$774M
Cap. Flow
% of AUM
3.9%
Top 10 Holdings %
Top 10 Hldgs %
22.92%
Holding
1,110
New
158
Increased
343
Reduced
427
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
lululemon athletica
LULU
|
+$160M |
| 2 |
Old Dominion Freight Line
ODFL
|
+$113M |
| 3 |
Intel
INTC
|
+$107M |
| 4 |
Mastercard
MA
|
+$104M |
| 5 |
PayPal
PYPL
|
+$104M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$292M |
| 2 |
FedEx
FDX
|
+$188M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$173M |
| 4 |
Monster Beverage
MNST
|
+$135M |
| 5 |
Target
TGT
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.45% |
| 2 | Financials | 14.27% |
| 3 | Consumer Discretionary | 14.13% |
| 4 | Healthcare | 11.46% |
| 5 | Industrials | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONL
651
Orion Office REIT
ONL
$148M
| $1.52M | 0.01% |
+265,266
| New | +$1.38M |
|
652
Preformed Line Products
PLPC
$1.45B
| $1.51M | 0.01% |
11,316
| – | – |
|
653
Trustmark
TRMK
$2.74B
| $1.51M | 0.01% |
54,141
-33,304
| -38% | -$772K |
|
|
TSP
654
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $1.5M | 0.01% |
1,709,504
+796,844
| +87% | +$814K |
|
655
Praxis Precision Medicines
PRAX
$8.25B
| $1.48M | 0.01% |
66,488
+20,929
| +46% | +$377K |
|
|
PSTX
656
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $1.47M | 0.01% |
+438,326
| New | +$1.13M |
|
657
Sutro Biopharma
STRO
$393M
| $1.46M | 0.01% |
34,028
-8,541
| -20% | -$271K |
|
658
Design Therapeutics
DSGN
$741M
| $1.46M | 0.01% |
+549,118
| New | +$1.26M |
|
659
Ligand Pharmaceuticals
LGND
$5.94B
| $1.45M | 0.01% |
20,279
-4,053
| -17% | -$239K |
|
660
Arcturus Therapeutics
ARCT
$163M
| $1.43M | 0.01% |
45,454
+36,128
| +387% | +$859K |
|
|
HTB
661
HomeTrust Bancshares
HTB
$856M
| $1.43M | 0.01% |
53,000
-5,628
| -10% | -$129K |
|
|
BRSL
662
Brightstar Lottery PLC
BRSL
$1.92B
| $1.42M | 0.01% |
51,893
-3,047
| -6% | -$85.3K |
|
663
LyondellBasell Industries
LYB
$18.8B
| $1.42M | 0.01% |
14,917
+1,989
| +15% | +$186K |
|
664
Vera Bradley
VRA
$104M
| $1.42M | 0.01% |
183,848
-1,183
| -0.6% | -$8.61K |
|
665
Eli Lilly
LLY
$1.09T
| $1.41M | 0.01% |
2,423
-2,060
| -46% | -$1.2M |
|
666
Invivyd
IVVD
$175M
| $1.41M | 0.01% |
357,735
-60,217
| -14% | -$114K |
|
|
TRUE
667
DELISTED
TrueCar
TRUE
| $1.39M | 0.01% |
400,328
-161,365
| -29% | -$409K |
|
|
NAPA
668
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $1.37M | 0.01% |
139,222
-17,300
| -11% | -$175K |
|
|
VRNT
669
DELISTED
Verint Systems
VRNT
| $1.36M | 0.01% |
+50,494
| New | +$1.17M |
|
670
Ooma
OOMA
$608M
| $1.35M | 0.01% |
126,249
-10,214
| -7% | -$116K |
|
671
Arteris
AIP
$1.34B
| $1.35M | 0.01% |
229,243
+18,229
| +9% | +$103K |
|
672
Northrim BanCorp
NRIM
$600M
| $1.35M | 0.01% |
94,392
-48,120
| -34% | -$568K |
|
673
Latham Group
SWIM
$673M
| $1.34M | 0.01% |
510,402
+417,435
| +449% | +$1.03M |
|
674
Erasca
ERAS
$6.3B
| $1.34M | 0.01% |
+629,282
| New | +$1.33M |
|
675
PMV Pharmaceuticals
PMVP
$58.7M
| $1.33M | 0.01% |
+429,642
| New | +$1.14M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2023 Portfolio in Review
As of Q4 2023, Jacobs Levy Equity Management held 1,110 positions worth $19.8B, up 18% from $16.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Jacobs Levy Equity Management deployed $774M of net new capital in Q4 2023, opening 158 new positions and adding to 343 existing holdings. Its largest new stake was lululemon athletica: 370,681 shares worth $190M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $292M trimmed.
- Jacobs Levy Equity Management's largest Q4 2023 buy was lululemon athletica: 370,681 shares worth $190M.
- Jacobs Levy Equity Management added most to Old Dominion Freight Line in Q4 2023, an estimated $113M increase.
- Jacobs Levy Equity Management's biggest Q4 2023 reduction was Meta Platforms (Facebook), cutting an estimated $292M.
- Jacobs Levy Equity Management fully exited Okta in Q4 2023, selling an estimated $57.8M.
- Jacobs Levy Equity Management's ten largest holdings make up 23% of its $19.8B portfolio in Q4 2023.
- Jacobs Levy Equity Management opened 158 new positions and closed 147 in Q4 2023.
- Jacobs Levy Equity Management's portfolio value rose 18% quarter-over-quarter to $19.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2023, filed 14 Feb 2024.